A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment

Rina Yue Ling Ong; Valerie Xue Fen Seah; Chia Yin Chong; Koh Cheng Thoon; Natalie Woon Hui Tan; Jiahui Li; Karen Donceras Nadua; Shui Yen Soh; Michaela Su-Fern Seng; Thi Ngoc Anh Pham; Chee Fu Yung; Kai-Qian Kam

doi:10.1080/0284186X.2023.2169079

A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment

Acta Oncol. 2023 Jan;62(1):53-57. doi: 10.1080/0284186X.2023.2169079. Epub 2023 Jan 20.

Authors

Rina Yue Ling Ong¹, Valerie Xue Fen Seah¹, Chia Yin Chong^{2

3

4

5}, Koh Cheng Thoon^{2

3

4

5}, Natalie Woon Hui Tan^{2

3

4

5}, Jiahui Li^{2

3

4

5}, Karen Donceras Nadua^{2

3

4

5}, Shui Yen Soh^{3

4

5

6}, Michaela Su-Fern Seng^{3

4

5

6}, Thi Ngoc Anh Pham⁷, Chee Fu Yung^{2

4

5}, Kai-Qian Kam^{2

3

4

5}

Affiliations

¹ Department of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore.
² Infectious Disease Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
³ Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
⁴ Duke-National University of Singapore Medical School, Singapore, Singapore.
⁵ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
⁶ Haematology/Oncology Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
⁷ Nursing Clinical Services, Division of Nursing, KK Women's and Children's Hospital, Singapore, Singapore.

PMID: 36661030
DOI: 10.1080/0284186X.2023.2169079

No abstract available

MeSH terms

COVID-19 Drug Treatment
COVID-19*
Child
Cohort Studies
Humans
Neoplasms* / complications
Neoplasms* / drug therapy

Substances

remdesivir